Céline JaudouinSenior Formulation Scientist at Alaya.bioSpeaker
Profile
Céline Jaudoin holds a PhD in Nanomedicine from Institut Galien Paris-Saclay. Since joining Alaya.bio at its inception four years ago, she has led the formulation design and development of the company's lentivector-based nanoparticle platform for in situ CAR-T cell therapy.
Agenda Sessions
Bridging Viral and Lipid Nanoparticle Worlds: Surface Engineering Lentiviral Vector-Based Nanoparticles for Targeted In Situ CAR-T Cell Therapy
, 09:10View Session

